By Josh White
Date: Friday 24 May 2024
(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced on Friday that it has received initial orders for its Genedrive MT-RNR1 products from five additional UK hospitals in the Greater Manchester area.
The AIM-traded firm said the hospitals included the Royal Oldham Hospital, Stepping Hill Hospital, Royal Bolton Hospital, Royal Albert...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news